Skip to main content

Lobbying activity

Who's lobbying Congress, for whom, and on what, from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 165 filings

Top spenders & firms Spend by issue Political contributions Revolving door

  Showing filings that named S 832. Clear
Clear
Q4
WILLIAMS AND JENSEN, PLLC for PHRMA
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $50,000.00 income
Medicare/Medicaid, Health Issues, Budget/Appropriations, Defense
View →
Q4
THE MCMANUS GROUP for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $60,000.00 income
Health Issues, Medicare/Medicaid
View →
Q4
THE MCMANUS GROUP for GILEAD SCIENCES, INC.
4th Quarter (Oct 1 - Dec 31) 2025 · California · House · Senate · $60,000.00 income
Health Issues, Medicare/Medicaid
View →
Q4
BAYER CORPORATION (CONSOLIDATED REPORT) for BAYER CORPORATION (CONSOLIDATED REPORT)
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate
Agriculture, Budget/Appropriations, Copyright/Patent/Trademark, Health Issues
View →
Q4
NEUROCRINE BIOSCIENCES, INC for NEUROCRINE BIOSCIENCES, INC
4th Quarter (Oct 1 - Dec 31) 2025 · California · House · Senate
Medicare/Medicaid, Health Issues, Budget/Appropriations, Taxation/Internal Revenue Code
View →
Q4
DLA PIPER LLP (US) for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $60,000.00 income
Budget/Appropriations, Defense, Trade (domestic/foreign), Copyright/Patent/Trademark
View →
Q4
DLA PIPER LLP (US) for NOVARTIS
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $60,000.00 income
Taxation/Internal Revenue Code, Trade (domestic/foreign), Copyright/Patent/Trademark, Health Issues
View →
Q4
TAKEDA PHARMACEUTICALS AMERICA, INC. for TAKEDA PHARMACEUTICALS AMERICA INC
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate
Budget/Appropriations, Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code
View →
Q4
LUNDBECK LLC for LUNDBECK LLC
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate
Health Issues, Medicare/Medicaid, Trade (domestic/foreign)
View →
Q4
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate
Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid
View →
Q4
AARP for AARP
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate
Civil Rights/Civil Liberties, Health Issues, Medicare/Medicaid, Pharmacy
View →
Q4
BIOGEN for BIOGEN
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate
Medicare/Medicaid, Pharmacy, Taxation/Internal Revenue Code, Trade (domestic/foreign)
View →
4A
HARNED STRATEGIES LLC for JOB CREATORS NETWORK
4th Quarter (Oct 1 - Dec 31) 2025 · Texas · House · Senate · $5,250.00 income
Budget/Appropriations, Education, Health Issues, Labor Issues/Antitrust/Workplace
View →
Q4
HARNED STRATEGIES LLC for JOB CREATORS NETWORK
4th Quarter (Oct 1 - Dec 31) 2025 · Texas · House · Senate · $6,000.00 income
Budget/Appropriations, Education, Health Issues, Government Issues
View →
Q4
OTSUKA AMERICA PHARMACEUTICAL, INC. for OTSUKA AMERICA PHARMACEUTICAL, INC.
4th Quarter (Oct 1 - Dec 31) 2025 · Maryland · House · Senate
Medicare/Medicaid, Health Issues, Budget/Appropriations, Taxation/Internal Revenue Code
View →
Q4
CROSSROADS STRATEGIES, LLC for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $50,000.00 income
Health Issues, Medicare/Medicaid, Copyright/Patent/Trademark, Trade (domestic/foreign)
View →
Q4
IONIS PHARMACEUTICALS, INC. for IONIS PHARMACEUTICALS, INC.
4th Quarter (Oct 1 - Dec 31) 2025 · California · House · Senate
Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code
View →
Q4
FORBES-TATE for NOVARTIS, INC.
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $50,000.00 income
Health Issues, Medicare/Medicaid, Trade (domestic/foreign), Budget/Appropriations
View →
Q4
ADVANCED POLICY CONSULTING, LLC for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA)
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $40,000.00 income
Health Issues
View →
Q4
DESIMONE CONSULTING, LLC for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA)
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $40,000.00 income
Pharmacy
View →
Q4
PERSONALIZED MEDICINE COALITION for PERSONALIZED MEDICINE COALITION
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate
Health Issues, Budget/Appropriations
View →
Q4
PUBLIC CITIZEN for PUBLIC CITIZEN
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate
Banking, Civil Rights/Civil Liberties, Computer Industry, Consumer Issues/Safety/Products
View →
Q4
THE KPM GROUP DC LLC for SOLENO THERAPEUTICS, INC.
4th Quarter (Oct 1 - Dec 31) 2025 · California · House · Senate · $50,000.00 income
Health Issues
View →
Q4
ELITE STRATEGIC SERVICES for CONSERVATIVES FOR PROPERTY RIGHTS
4th Quarter (Oct 1 - Dec 31) 2025 · South Carolina · House · Senate · $100,000.00 income
Copyright/Patent/Trademark, Health Issues, Labor Issues/Antitrust/Workplace, Taxation/Internal Revenue Code
View →
Q4
LMH STRATEGIC SOLUTIONS for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $30,000.00 income
Medicare/Medicaid, Pharmacy
View →
Previous Page 3 of 7 Next

Source: federal Lobbying Disclosure Act filings. A filing's bill references are parsed from its activity descriptions, so a bill page shows the filings that named it.

Report a problem